Donal Carroll Insider Profile
11 Followers
Donal Carroll, Chief Financial Officer at Quantum Biopharma, holds 0.00 shares in Quantum Biopharma (Ticker: QNTM), holds 2.90M shares in Hash Corporation (Ticker: TSE:STRC.X), holds 483.33K shares in Bird River Resources (Ticker: TSE:BDR). Most recently, Donal Carroll Sold ― shares of Quantum Biopharma on Apr 09, 2026 for an estimated value of $55.55K.
Donal Carroll Quantum Biopharma (QNTM)Chief Financial Officer
Quantum Biopharma (QNTM)
Chief Financial Officer
Ranked #1,304 out of 109,349 Corporate Insiders
Profitable Transactions
25 out of 32 Profitable Transactions
Average Return
+28.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Donal Carroll holds in companies
Most Profitable Insider Trade
The most profitable trade made by Donal Carroll
Donal Carroll's Trading History
Quantum Biopharma
Apr 09, 2026
Chief Financial Officer
Informative Sell
55.55K
$0.00
Hash Corporation
Jun 01, 2021
Executive
Uninformative Sell
14.50K
C$29.00K
Bird River Resources
―
Director
―
C$65.25K
Cannara Biotech
Jun 05, 2023
Divisional Vice-President
Informative Buy
2.93K
$4.47K
Stock Trend Capital
May 28, 2019
Chief Financial Officer, Ten Percent Owner
Informative Buy
32.00K
―
List of latest transactions for each holding click on a transaction to see Donal Carroll's performance on stock
You May Also Like
Donal Carroll insider profile FAQ
What is the percentage of profitable transactions made by Donal Carroll?
The percentage of profitable transactions made by Donal Carroll is 78%.
What is the average return per transaction made by Donal Carroll?
The average return per transaction made by Donal Carroll is 28.40%.
What stocks does Donal Carroll hold?
Donal Carroll holds: QNTM, TSE:STRC.X, TSE:BDR, LOVFF, STOCF stocks.
What was Donal Carroll’s latest transaction?
Donal Carroll latest transaction was an Informative Sell of $55.55K.
What was Donal Carroll's most profitable transaction?
Donal Carroll’s most profitable transaction was an Informative Sell of QNTM stock on October 10, 2018. The return on the trade was 91.80%.
What is Donal Carroll's role in Quantum Biopharma?
Donal Carroll's role in Quantum Biopharma is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.